Frontiers2 天
Role of released mitochondrial DNA in acute lung injury
Acute lung injury(ALI)/acute respiratory distress syndrome(ARDS) is a form of acute-onset hypoxemic respiratory failure characterised by an acute, diffuse ...
Investing2 天
CalciMedica reports reduced mortality in AKI trial with Auxora
CalciMedica is advancing its research with ongoing trials, including the Phase 2 KOURAGE study in AKI patients with acute hypoxemic respiratory failure, expected to conclude in 2025. The company ...
Le Lézard1 天
CalciMedica Secures Credit Facility for Up to $32.5 Million
CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...
Investing2 天
CalciMedica reports reduced mortality in AKI trial with Auxora
CalciMedica is advancing its research with ongoing trials, including the Phase 2 KOURAGE study in AKI patients with acute hypoxemic respiratory failure, expected to conclude in 2025. The company also ...
The Lancet5 天
Ventilatory support after extubation in critically ill patients
bClinical Department of Anaesthesiology and Intensive Care Medicine, SS. Annunziata Hospital, Chieti, Italy ...
Medscape5 天
Sleep Parameters in Patients Using Pacemakers with Sleep Rate Function On
Introduction: The cardiovascular system (CVS) is heavily influenced by the autonomic nervous system. Additionally, there is a functional alteration during the various stages of sleep. In nonrapid ...